Evidence map›Paper›PMID 21091666›Full record

ArticleClinical and experimental immunology2011

Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression.

A C Maretti-Mira, M P de Oliveira-Neto, A M Da-Cruz, M P de Oliveira, N Craft, C Pirmez

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Deciphering Host-Parasite Interplay inACS infectious diseases · 2024
    Article
  3. Article
  4. Article
  5. Insights intoVeterinary sciences · 2021
    Review
  6. Observational
  7. Article
  8. Cytotoxic activity in cutaneous leishmaniasis.Memorias do Instituto Oswaldo Cruz · 2017
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

A C Maretti-MiraInstituto Oswaldo Cruz at FIOCRUZ, Rio de Janeiro, RJ, Brazil. anamaretti@ioc.fiocruz.br
M P de Oliveira-Neto
A M Da-Cruz
M P de Oliveira
N Craft
C Pirmez
Fundação Oswaldo Cruz · BRHarbor–UCLA Medical Center · USUCLA Medical Center · US

Funding

Immunomodulation in melanoma therapyR01CA127565 · NCI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI CRAFT, NOAH A · 2008 to 2012
$1.8M
NCI NIH HHS R01 CA127565
6 · The paper itself

Abstract

Cutaneous lesions caused by Leishmania braziliensis infection occasionally heal spontaneously, but with antimonials therapy heal rapidly in approximately 3 weeks. However, about 15% of the cases require several courses of therapy. Matrix metalloproteinase-2 (MMP-2) and MMP-9 are gelatinases that have been implicated in other chronic cutaneous diseases and skin re-epithelialization. These enzymes are controlled by their natural inhibitors [tissue inhibitors of metalloproteinase (TIMPs)] and by some cytokines. Uncontrolled gelatinase activity may result in intense tissue degradation and, consequently, poorly healing wounds. The present study correlates gelatinase activity to therapeutic failure of cutaneous leishmaniasis (CL) lesions. Our results demonstrate an association between gelatinase activity and increased numbers of cells making interferon (IFN)-γ, interleukin (IL)-10 and transforming growth factor (TGF)-β in lesions from poor responders. Conversely, high levels of MMP-2 mRNA and enhanced MMP-2 : TIMP-2 ratios were associated with a satisfactory response to antimonials treatment. Additionally, high gelatinolytic activity was found in the wound beds, necrotic areas in the dermis and within some granulomatous infiltrates. These results indicate the importance of gelatinase activity in the skin lesions caused by CL. Thus, we hypothesize that the immune response profile may be responsible for the gelatinase activity pattern and may ultimately influence the persistence or cure of CL lesions.

Indexed as

AdultAntimonyAntiprotozoal AgentsCytokinesFemaleHumansInterferon-gammaInterleukin-10Leishmaniasis, CutaneousMaleMatrix Metalloproteinase 2Matrix Metalloproteinase 9MeglumineMeglumine AntimoniateOrganometallic CompoundsRegenerationAntimonyAntiprotozoal AgentsCytokinesInterferon-gammaInterleukin-10Matrix Metalloproteinase 2Matrix Metalloproteinase 9MeglumineMeglumine AntimoniateMMP2 protein, humanOrganometallic CompoundsTransforming Growth Factor beta

Identifiers

PMID21091666
PMCPMC3043311
OpenAlexW1522088911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.